Join the study to help us learn about the safety of using Nurtec® ODT (rimegepant) and other migraine medications during pregnancy. A pregnacy registry is a study that collects health information from women who take prescription medicines when they are pregnant.
You may be eligible if you are:
*Please note: If you have taken certain migraine medications (e.g., Reyvow®, Ubrelvy®, Aimovig®, Ajovy®, Emgality®, Qulipta™, or Vyepti®) prior to or during pregnancy you may not be eligible to participate. The registry staff can help determine your eligibility if you have taken these medications.
Nurtec® ODT is a prescription medicine made by Biohaven Pharmaceuticals that is used to treat migraine in adults.
It is for the:
Future pregnant women with migraine, doctors, and researchers can benefit from the information you provide to the registry.
If you are eligible and would like to participate, you will be asked to:
You and your healthcare provider(s) will provide information to the registry about your pregnancy and your baby’s health up to 1 year of age. This information can be provided by completing paper forms, via the free registry app, via the website portal or via short phone interviews with one of the registry staff members. Only information normally documented in your medical record will be collected.
If you participate, there will be:
You and your healthcare provider(s) will receive compensation for providing data to the registry.
If you are eligible and would like to participate, you will be asked to provide information to the registry at enrollment and periodically throughout your pregnancy:
You will be paid for each month that you provide data to the registry.